div class=”ChapterContextInformation”>
59. Tumor Lysis Syndrome: Cancer Toxic Dump
Keywords
HyperkalemiaHyperphosphatemiaHypocalcemiaUric AcidCalcium phosphateAllopurinolRasburicaseRenal failureSeizureArrhythmiaChemotherapyCase
Pertinent History
This patient is a 65 year-old-male with a past medical history (PMH) of diabetes mellitus (DM), coronary artery disease (CAD) s/p left anterior descending artery (LAD) stent who was recently diagnosed with diffuse large B-cell lymphoma (DLBCL), the most common variety of Non-Hodgkin’s Lymphoma (NHL) He presented with generalized fatigue, muscle cramps, nausea, difficulty urinating, and palpitations. He initiated R-CHOP* chemotherapy 3 days ago. Since then, he has had nausea, generalized fatigue and muscle cramping. Today he also noticed difficulty urinating and sensations of “his heart flip-flopping.” He denies any chest pain, shortness of breath or syncope. He denies any fevers or chills, cough or changes in bowel habits. *Rituximab, cyclophosphamide, hydroxydanorubicin, Oncovin (vincristine) and prednisone.
Pertinent Physical Exam
Except as noted below, the findings of the complete physical exam are within normal limits.
Temperature: 100.6 °F/38.1 °C, Blood Pressure: 135/65, Heart Rate: 105, Respiratory Rate: 18, Peripheral capillary oxygen saturation (SpO2): 99% on room air.
General: Alert, ill-appearing, oriented times 3
HEENT: mucous membranes dry, positive Chvostek’s sign, conjunctivae are pale
Cardiovascular: tachycardic
Past Medical History
Non-Hodgkin’s Lymphoma with 10 cm mediastinal mass and positive inguinal lymph nodes, DM not on insulin, CAD s/p LAD stent 2 years prior
Social History
social alcohol use, denies illicit drugs and smoking
Family History
CAD father, DM mother
Pertinent Test Results
EKG
Sinus Tachycardia, with peaked T-waves, no ST elevations or depressions
Lab results | |||
---|---|---|---|
Test | Results | Units | Normal range |
WBC | 4.3 | K/uL | 3.8–11.0 103 / mm3 |
Hgb | 8.9 | g/dL | (Male) 14–18 g/dL (female) 11–16 g/dL |
Platelets | 35 | K/uL | 140–450 K /uL |
BUN | 23 | mg/dL | 6–23 mg/dL |
Creatinine | 2.4 | mg/dL | 0.6–1.5 mg/dL |
Potassium | 7.4 | mEq/L | 3.5–5.5 mEq/L |
Chloride | 105 | mEq/L | 96–112 mEq/L |
Bicarbonate | 21 | mEq/L | 21–34 mEq/L |
Glucose | 145 | mg/dL | 65–99 mg/dL |
Calcium | 6.5 | mg/dL | 8.6–10.5 mg/dL |
Troponin | <0.01 | ng/ml | < 0.04 |
Uric acid | 12.1 | mg/dL | 3.5–7.7 mg/dL |
Phosphate | 6.2 | mg/dL | 2.2–4.6 mg/dL |
Emergency Department Management
Based on the patient’s History and Physical exam findings, concern for electrolyte imbalance due to Tumor Lysis Syndrome (TLS) is suspected. With patient history of CAD and palpitations, cardiac work up was also ordered. Electrolytes, EKG, and Complete Blood Count were ordered. EKG was found to have peaked T-waves concerning for hyperkalemia. Hyperkalemia treatment was initiated including calcium gluconate and bicarbonate.
Labs returned confirming hyperkalemia and revealing also hypocalcemia and acute kidney injury (AKI) with elevated creatinine. Patient was given insulin and D5 0.9% Normal saline boluses to treat hyperkalemia and AKI. Further labs including phosphate and uric acid were ordered. The oncology team was consulted for inpatient admission and management.
Updates on ED Course
After 2 L boluses were given , repeat electrolytes revealed potassium levels to be 6.4 mmol/L. Patient also had continued physical exam findings supportive of symptomatic hypocalcemia.
Learning Points
Priming Questions
- 1.
When to suspect tumor lysis syndrome? Risk factors and the time period in which one should expect tumor lysis.
Full access? Get Clinical Tree